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KEHADIRAN PROTEIN KEJUTAN HABA YANG ANTIGENIK DAN 
SPESIFIK BAGI Shigella flexneri DAN Shigella sonnei 
 
ABSTRAK 
 
Shigellosis adalah penyakit berjangkit yang membimbangkan awam terutamanya di 
negara-negara yang sedang membangun dan ianya adalah disebabkan oleh Shigella 
spp.. Oleh kerana kebangkitan global spesies Shigella yang rintang terhadap 
antibiotik, pilihan agen antimikrob untuk rawatan shigellosis adalah sangat terhad. 
Pengenalpastian bakteria pada masa kini adalah dengan menggunakan kaedah 
pengkulturan konvensional dan ujian biokimia yang mengambil masa lebih kurang 2 
hingga 7 hari. Justeru itu, terdapat keperluan untuk membangunkan ujian pantas yang 
boleh memberi keputusan yang tepat supaya rawatan segera dapat diberikan kepada 
pesakit shigellosis. Pembangunan ujian yang spesifik dan sensitif memerlukan 
penemuan penanda bio yang tidak bertindakbalas silang dengan bakteria lain dan 
spesifik hanya untuk Shigella spp. Protein kejutan haba (HSP) adalah protein yang 
diekspresi oleh bakteria semasa ia mengalami tekanan daripada persekitaran dan 
protein ini juga berpotensi untuk dijadikan sebagai penanda bio dalam bidang 
diagnostik. Oleh itu, tujuan kajian ini dilakukan adalah untuk mengenalpasti 
kehadiran HSP dan penanda bio daripada protein membran luar (OMP) terhadap S. 
flexeri dan S. sonnei. 
Di dalam kajian ini, profil protein daripada strain ATCC dan strain klinikal S. 
flexneri dan S. sonnei didemonstrasi dengan menggunakan teknik SDS-PAGE. Profil 
OMP daripada sel S. flexneri dan S. sonnei yang diekspres pada suhu 37°C 
dibandingkan dengan profil yang diperolehi pada suhu 38.5°C dan 40°C (suhu pada 
pesakit yang mengalami demam semasa shigellosis) untuk menilai kesan suhu 
xiii 
 
terhadap ekspresi protein membran luar (OMP). Kajian ini menunjukkan bahawa 
tahap pengekspresian OMPs S. flexneri dan S. sonnei berubah dengan peningkatan 
suhu yang diuji.  
Elektroforetogram protein tersebut seterusnya dianalisis dengan blot Western 
menggunakan serum pesakit yang dijangkiti oleh S. sonnei dan S. flexneri serta 
semua jangkitan lain yang berkaitan. Sera daripada jangkitan S. flexneri 
menunjukkan 11 jalur antigenik terhadap antibodi IgA dan IgG. Manakala, sera 
daripada jangkitan S. sonnei menunjukkan 14 dan 11 jalur antigenik terhadap 
antibodi IgA dan IgG masing-masing. Kesemua jalur antigenik diuji samada 
bertindak balas silang dengan serum daripada pesakit yang dijangkiti oleh 
Salmonella spp., enteropathogenic Escherichia coli, Salmonella Typhi, Aeromonas 
hydrophila dan Campylobacter jejuni. Tiga jalur protein (33.3, 43.8 and 100.3 kDa) 
daripada S. sonnei dan 2 jalur protein (25.6 and 63.2 kDa) daripada S. flexneri tidak 
menunjukkan tindak balas silang terhadap serum daripada jangkitan bakteria lain dan 
ini mencadangkan bahawa protein ini adalah spesifik terhadap S. sonnei dan S. 
flexneri. 
Kehadiran protein kejutan haba yang menunjukkan kuantiti ekspresi yang tinggi 
telah dikenalpasti melalui kaedah MALDI-ToF-ToF. Protein kejutan haba bersaiz 
18.4, 25.6 dan 57.0 kDa daripada S. flexneri dikenalpasti sebagai Dps, WrbA dan 
PepA melalui kaedah ini. Manakala, protein kejutan haba bersaiz 43.8 dan 100.3 kDa 
daripada S. sonnei telah dikenalpasti sebagai Pbp dan AceE. Peningkatan ekspresi 
protein-protein ini berkemungkinan bertindak sebagai mekanisma pertahanan oleh 
bakteria terhadap suhu tinggi dalam badan pesakit dan protein-protein ini berpotensi 
untuk digunakan sebagai penanda bio dalam pembangunan ujian diagnostik segera 
bagi shigellosis. 
xiv 
 
Protein-protein spesifik terhadap S. flexneri dan S. sonnei yang dikenalpasti boleh 
digunakan sebagai penanda bio untuk pembangunan ujian diagnostik yang 
membolehkan diagnosis yang tepat dan cepat bagi mengesan shigellosis untuk 
pengawalan wabak penyakit. 
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PRESENCE OF ANTIGENIC AND SPECIFIC HEAT SHOCK PROTEIN(S) 
OF Shigella flexneri AND Shigella sonnei 
 
ABSTRACT 
 
Shigellosis caused by Shigella spp. is a public health concern in developing 
countries. Due to global emergence of drug resistance to Shigella spp., the choice of 
antimicrobial agents to treat shigellosis is limited. Current identification of this 
pathogen is by conventional culture method and biochemical tests, which takes about 
2 to 7 days to produce result. Hence, there is a need for a rapid and reliable test that 
would allow rapid management of shigellosis infections. Development of a specific 
and sensitive diagnostic test requires discovery of biomarker(s), which does not cross 
react with other bacteria and are specific only to Shigella spp .Heat shock proteins 
(HSP) are proteins expressed in bacteria during stress environment and these proteins 
have potential as biomarker in diagnostic field. Thus the aim of this study is to detect 
the presence of HSPs and biomarker(s) in the outer membrane proteins (OMPs) of S. 
flexneri and S. sonnei.  
Protein profiles of OMPs from the ATCC strain and clinical isolate of S. flexneri and 
S. sonnei were demonstrated using the technique of Sodium Dodecyl Sulfate-Poly 
Acrylamide Gel Electrophoresis (SDS-PAGE). The OMPs profiles of S. flexneri and 
S. sonnei expressed at 37°C was compared with the profiles of 38.5°C and 40°C 
(temperature in patients with fever during shigellosis) to assess the effect of 
temperature on the expression of the OMPs. 
xvi 
 
This study demonstrated that the expression level of OMPs of S. flexneri and S. 
sonnei varies with increasing temperatures.  
The protein electrophoretograms were subjected to Western blot using serum from 
patients infected with S. sonnei and S. flexneri as well other related infections. Result 
of this study demonstrated 11 antigenic bands were detected when probed with sera 
from patients with S. flexneri infection against both anti-human IgA and IgG 
isotypes. A total of 14 and 11 antigenic bands were obtained against anti-human IgA 
and IgG respectively when probed with sera from S. sonnei infection. All the 
antigenic bands were checked for cross reactivity using sera from patients infected 
with Salmonella spp., Enteropathogenic Escherichia coli, Salmonella Typhi, 
Aeromonas hydrophila and Campylobacter jejuni. Three protein bands (33.3, 43.8 
and 100.3 kDa) of the S. sonnei and 2 protein bands (25.6 and 63.2 kDa) of the S. 
flexneri did not cross reacted with sera from other infections, suggesting that these 
proteins are specific biomarker for S. flexneri and S. sonnei. 
The identified HSPs showing prominent increased in expression were further 
identified by MALDI-ToF-ToF analysis. The HSPs of 18.4, 25.6 and 57.0 kDa in 
size from S. flexneri were identified as Dps, WrbA and PepA respectively. Whereas, 
the HSPs of 43.8 and 100.3 kDa in size from S. sonnei were identified as Pbp and 
AceE. The increased expression of these proteins probably is a mechanism of 
survival of the bacterium at higher temperatures in the host body and could be 
potential diagnostic biomarkers. Therefore these identified specific proteins for S. 
flexneri and S. sonnei can be used as biomarkers for development of diagnostic test 
which would allow rapid and accurate diagnosis of shigellosis to control the disease 
outbreak.  
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CHAPTER ONE 
INTRODUCTION 
 
1.1  Introduction to Shigella 
1.1.1  Historical perspectives and importance of Shigella discovery 
Bacillary dysentery or also known as shigellosis is an acute infection caused by 
Shigella spp., a gram negative, non-motile bacillus. Shigellosis often characterized 
by abdominal cramps, fever and frequent mucoid bloody stools. Isolation of this 
bacterium from feces of individuals with acute dysentery was first described by 
Chantemese and Widel in 1888 (Lan and Reeves, 2002). Later, in 1898 a young 
Japanese microbiologist Kiyoshi Shiga had reported detailed description of the 
organism that caused the dysentery and named the organism as Bacillus dysenteriae 
(Yabuuchi, 2002). In late 1940, genus Shigella was classified into 4 species: Shigella 
dysenteriae, Shigella flexneri, Shigella boydii and Shigella sonnei and which are also 
designated as group A, B, C, and D respectively (Gangarosa et al., 1970). 
 
In the earlier classification, Shigella and Escherichia coli were classified in the same 
genus because of their genetic similarity. Several studies have reported that they 
share genetic homology greater than 90% (Boileau et al., 1984; Faruque et al., 2002). 
However, a comparative genomic study between the two organisms revealed that 175 
of the total 3235 open reading frames were exclusive for S. flexneri (Wei et al., 
2003). Shigella strains were grouped in a different genus from E. coli because of 
their medical significance, human host interactions, pathogenicity, and physiology 
and serological characteristics (Escobar-Paramo et al., 2003). 
 
2 
 
1.1.2  Global epidemiology of shigellosis 
Shigellosis is a public health concern in developing countries and for travellers from 
industrialized nations (Vila et al., 1994). The annual numbers of shigellosis episodes 
and deaths in Asia were estimated to be 91 million and 414,000, respectively, with S. 
flexneri and S. sonnei being the first and second most common serotypes (WHO, 
2005). Shigella known as a disease of all age group but it is commonly seen in 
paediatric patients less than 5 years of age group (Arya et al., 1977; Mutanda et al., 
1979; MoezArdalan et al., 2003). Studies have reported that in developing countries, 
majority of Shigella infections are due to endemic shigellosis which causes 
approximately 10% of all diarrhoeal cases among children younger than five years 
old (Bennish and Wojtyniak, 1991). 
 
In developing countries, the isolates of S. flexneri, S. sonnei, S. boydii and S. 
dysenteriae accounted for 60%, 15%, 6% and 6% respectively; and 16%, 77%, 2% 
and 1% respectively, in developed countries (Kotloff et al., 1999). A study 
conducted in Singapore between 1986 and 1990 on total Shigella isolates had 
reported that S. flexneri was the most frequently isolated strains (60.3%) followed by 
S. sonnei (33.6%), S. boydii (3.2%) and S. dysenteriae (3%) (Lim and Tay, 1991).  
 Shigellosis outbreaks are mostly due to contaminated water, food, overcrowding 
communities, food handlers and flies (Kapperud et al., 1995; Shears, 1996; Brooks et 
al., 2003). A case control study conducted in rural Western Kenya to characterize the 
epidemiology of bloody diarrhea reported that 80% of bacterial pathogens isolated 
were due to Shigella spp., of which approximately 49% was caused by S. flexneri 
(Brooks et al., 2003). Studies have also reported that, approximately 580,000 
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travellers from industrialized countries are infected annually by Shigella (Kotloff et 
al., 1999). 
 
In Malaysia, very few studies have been conducted to describe the prevalence of 
shigellosis. A retrospective study conducted on bacterial enteropathogens in 
childhood diarrhea in University Malaya Medical Centre (UMMC), Kuala Lumpur, 
from 1978 to 1997 showed that Shigella spp. was the third most common bacteria 
isolated from patient’s stool samples (Lee and Puthucheary, 2002). Shigella spp. was 
isolated from 1.4% (386 isolates) of total stool specimens, corresponding to 13% of 
the 2986 isolates positive for bacterial pathogens. S. flexneri found to be the most 
frequently isolated species reported which constituted 74% of all Shigella isolates. A 
9-year retrospective study conducted in Northeast Malaysia showed that the isolation 
rate was 9.99% of the total bacterial pathogens isolated from stool specimens, with S. 
sonnei and S. flexneri being the most common species isolated (Banga Singh et al., 
2011). 
 
1.1.3  Classification 
The genus Shigella is subdivided into four species based on the serological 
characteristics. Serotyping is based on the presence of O antigen component of 
lipopolysaccharides present on the outer membrane of the cell wall. S. dysenteriae 
consists of 13 serotypes. S. flexneri is subdivided into eight serotypes that are 1, 2, 3, 
4, 5, 6, X and Y, with eleven sub-serotypes that are 1a, 1b, 1c, 2a, 2b, 3a, 3b, 4a, 4b, 
5a and 5b. S. boydii consist of 23 serotypes and is least frequently isolated species 
from cases of bacillary dysentery. S. sonnei consist of single serotype but may occur 
in two forms which is phase 1 and phase 2. (Rahaman et al., 1975). 
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1.1.4  Bacteriology of Shigella 
1.1.4.1  Physical characteristics 
Shigellae are small, Gram-negative rods with a diameter of 0.3 to 1 µm and a length 
of 1 to 6 µm. They are non-motile, non-spore forming, noncapsulated and possess K 
and O antigens. The O antigen (somatic antigen) is useful in serological 
identification to classify the four species. The K antigen is the capsule antigen which 
occasionally interferes with agglutination by O antisera. Shiga toxin or verotoxin is 
an enterotoxin, which is produced only by Shigella dysenteriae type 1.  It is a multi-
subunit toxin made up of an A subunit (32 kDa), responsible for toxic action of the 
protein and five molecules of the B subunit (7.7 kDa), responsible for binding to a 
specific cell receptor (Mata et al., 1970). 
  
1.1.4.2  Growth and culture characteristics 
Shigella is a facultative anaerobe bacterium and is able to grow at temperatures 
ranging from 12oC to 48oC (optimum 37oC), at a pH range of 5.0 to 7.0 (Tetteh and 
Beuchat, 2003; Zaika and Phillips, 2005). Generally, death of Shigella are enhanced 
with increased in temperature, NaCl concentrations and decreased in pH. The 
organism is acid resistant and can easily pass the gastric acid barrier. The common 
selective and differential agar media used for the recovery of Shigella are 
MacConkey (MAC), Xylose Lysine Deoxycholate (XLD), Hektoen (HEK) and 
Salmonella-Shigella (SS) and Deoxycholate Citrate Agar (DCA). After overnight 
incubation, colonies on the MacConkey and DCA agar appears to be large, 2 to 3 
mm in diameter, translucent and colourless (non-lactose fermenting) due to the 
absence of lactose fermentation. An exception is S. sonnei which is a late lactose 
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fermenter and forms pale pink colonies after 24 hours incubation. Whereas, on the 
XLD agar, colonies appear to be much smaller (1 to 2 mm diameter) and red in 
colour as lysine is decarboxylated producing alkaline end products which raises the 
pH and cause the agar to turn into deep red colour. On the HEK agar, the colonies 
appear to be blue greenish colour. Shigella does not produce hydrogen sulphide 
(H2S) on the XLD, HEK and SS agar (Germani and Sansonetti, 2006). 
 
1.1.4.3  Biochemical characteristic 
Shigella does not ferment lactose but culture of S. sonnei ferments late lactose after 
24 hours incubation. Shigella utilizes glucose and other carbohydrates, producing 
acid but not gas except for the S. flexneri serotype 6 and is oxidase negative. All 
Shigella species ferment mannitol except S. dysenteriae. Normally, indole is not 
produced and methyl red (MR) test is positive. On Triple Sugar Iron (TSI) agar, 
Shigella isolates are glucose positive (yellow butt), lactose negative (alkaline red 
slant) and do not produce H2S gas. It is non-motile on Motility-Indole-Urea (MIU) 
agar. The suspected Shigella species will be further identified using serological test 
(Cheesbrough, 2006). 
 
1.2  Clinical significance of shigellosis 
1.2.1  Mode of transmission 
The only natural hosts for Shigella infection is human and primates. The 
predominant mode of transmission is by fecal-oral route, in which Shigella is usually 
transmitted from person to person. The bacterium is highly infectious, since as few as 
10 to 100 microorganisms are sufficient to cause disease (DuPont et al., 1989) as 
they able to survive in acidic environment in the stomach (Small et al., 1994). The 
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infective dose of Shigella is lower than that reported for most other enteric pathogens 
such as for Vibrio spp. and Salmonella spp. which require at least 104 to 105 
organisms to cause infection (Kothary and Babu, 2001). 
 
1.2.2  Pathogenesis  
The pathogenesis of shigellosis involves the invasion of the bacterium into the 
epithelial M cells of the colon. Upon contacting with the epithelium cell surface, 
Shigella releases Ipa (invasion proteins antigens) proteins through a specialized type 
III secretory apparatus (Sansonetti, 2001). The intrinsic invasive properties of the 
Shigella facilitate its invasion into the cell which damages the cell and cause 
inflammatory response (Zychlinsky and Sansonetti, 1997). Expression of various 
cells like M cells, epithelial cells, resident macrophages and polymorphonuclear 
leukocytes (PMNs) during Shigella invasion causes rupture, invasion and 
inflammatory destruction of the intestinal barrier (Sansonetti, 2001). The shigellosis 
pathogenic mechanism is complex which involves multiple genes during invasion 
and has been studied extensively by Sansonetti and colleagues (Goldberg and 
Sansonetti, 1993; Sansonetti et al., 1996).  
 
1.2.3  Clinical signs and symptoms 
Shigellosis is characterized by frequent small volume passage of stools that consist 
largely of blood, mucus and pus, accompanied by fever and stomach cramps. Blood, 
mucus and pus cells in the stools are the signs of colorectal inflammation (Li, 2000). 
These symptoms are also common in infections caused by other invasive 
microorganisms such as Campylobacter, Salmonella and Entamoeba histolytica. 
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However, in some cases, Shigella causes acute non-bloody diarrhea that cannot be 
distinguished clinically from diarrhea caused by other enteric pathogens.  
Shigellosis can be serious in some cases, especially involving young children and the 
elderly, which require hospitalization of the patients. Severe cases may become life 
threatening and contribute to substantial mortality. Severe infections with high fever 
have been associated with seizures among children (Khan et al., 1999). Patients with 
severe infection may pass more than 20 dysenteric stools in one day. Dysentery is 
also characterized by daily loss of 200-300 ml of serum protein into the faeces, 
which exacerbates malnutrition and growth stunting in young children living in 
developing countries (Alam et al., 2000). Depletion of immune system also increases 
the risk of shigellosis and contributes to substantial mortality (Simor et al., 1989; 
Gassama et al., 2001). Therefore, clinical signs and symptoms are very important in 
helping to identify and treat patients with shigellosis.  
 
1.2.4  Complications 
Persistent life-threatening complications are often seen in malnourished infants and 
young children living in developing countries and also in elderly people who have 
weakened immune system (Bennish and Wojtyniak, 1991). Shigellosis usually 
resolves within five to seven days without sequelae (Steffen et al., 1983). 
Complications include metabolic derangements, such as dehydration, hyponatraemia, 
hypoglycaemia, hypoproteinaemia and severe anorexia intestinal complications such 
as toxic megacolon, rectal prolapsed and intestinal perforation (Ashkenazi, 2004). 
HIV-infected and other immunocompromised patients have been reported as a risk 
factor associated with bacteraemia due to Shigella. Persistent diarrhea and 
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malnutrition are the most common chronic sequelae (Niyogi, 2005). Reactive 
inflammatory arthritis (Hannu et al., 2005), conjunctivitis and urethritis known as 
Reiter’s syndrome and anorexia has also been reported as complication due to 
shigellosis (Ashkenazi, 2004). Microangiopathic haemolytic anaemia can complicate 
infection with Shiga toxin-producing organisms, manifesting as the haemolytic 
uraemic syndrome (HUS) in children and as thrombotic thrombocytopenic purpura in 
adults (Koster et al., 1978). Shigellosis has also been associated with acute 
appendicitis in children and endometriosis in females (Kodati et al., 2008).  
 
1.2.5  Antimicrobial treatment and prevention 
World Health Organization has recommended that oral rehydration treatment is an 
effective and live-saving therapy for acute dehydrating watery diarrhea in the 
developing world. Treatment is critical in young children, the elderly or persons with 
chronic diseases, as shigellosis can be severe and lead to dehydration and other 
complication (Salam and Bennish, 1991). Antibiotic treatment also plays an 
important role in recovery from shigellosis. Appropriate antibiotic treatment, shorten 
the duration of excretion of Shigella, thus decrease the spreading of pathogens and 
prevent further complication. Multiple drug resistance plasmids are widely prevalent 
in Shigella spp. (Replogle et al., 2000). The choice of antibiotic should be based on 
the sensitivity of the prevailing strain. The main antibiotics used for shigellosis are 
ampicillin, tetracycline, amoxicillin, nalidixic acid, cotrimoxazole, chloramphenicol 
and trimethoprim-sulfamethoxazole. Ciprofloxacin is recommended as the first line 
treatment and pivecillinam, ceftriaxone or azithromycin as the second line treatment 
for Shigella infection (Christopher et al., 2010). However, treatment has become 
increasingly difficult due to emerging resistance to these commonly prescribed 
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antibiotics (Salam and Bennish, 1991; Replogle et al., 2000; Ke et al., 2011). Many 
studies have reported the emergence of multi-resistant strains to the commonly 
prescribed antibiotics occurring in the developing and developed countries (Replogle 
et al., 2000; Taneja et al., 2004; Pazhani et al., 2008; Schultsz and Geerlings, 2012). 
The Shigella resistance locus (SRL), have been identified in Shigella strains which 
have been reported to mediate resistance to antibiotics (Turner et al., 2001; Turner et 
al., 2003). A study conducted by Lee & Puthucheary in Malaysia, reported that out 
of 241 isolates tested for antibiotic sensitivity, 58% were resistant to at least one 
antibiotic, and 42% were multi-resistant to three or more antibiotics (Lee and 
Puthucheary, 2002). 
 
As the only significant source of Shigella infection is human and the mode of 
transmission is oral-faecal route, improving the personal and environmental 
sanitation are essential for disease prevention. The prevention measures include hand 
washing with soap, safe disposal of faeces, chlorination of water and protection of 
food from contamination. To date, there is no commercially vaccine available in the 
market to treat shigellosis (Das et al., 2013). 
 
1.3  Diagnosis of shigellosis 
1.3.1  Clinical diagnosis 
The diarrhoeal stage of the infection cannot be distinguished clinically from other 
bacterial, viral and protozoan infections (Youssef et al., 2000). Therefore clinical 
diagnosis of shigellosis is not specific. The presence of fever suggests an invasive 
pathogen. Patients presenting with watery diarrhea and fever should be suspected of 
having shigellosis but the differential diagnosis should include infection caused by 
10 
 
enteroinvasive E. coli (EIEC), Salmonella enteritidis, Campylobacter species and 
Entamoeba histolytica (Goodman and Segreti, 1999; Sur et al., 2004). The typical 
clinical feature of shigellosis is bloody and mucopurulent stool. Usually, fresh and 
bright red blood is present in the stools of patients infected with Shigella rather than 
dark brown blood which usually seen in amoebiasis (Niyogi, 2005). 
 
1.3.2  Laboratory diagnosis 
1.3.2.1  Conventional bacteriology techniques  
1.3.2.1.1  Stool examination 
Routine microbiological investigations in the laboratory diagnosis of shigellosis 
comprised of macroscopic and microscopic examinations of the suspected patients 
feces. Fecal specimens from patients with shigellosis will be watery, contains mucus 
and blood. The presence of red and white blood cells is an important characteristics 
in establishing the diagnosis of dysentery (Cheesbrough, 2006). Fresh and unstained 
suspensions of feces are examined directly under the microscope. Invasion of the 
intestinal wall and the consequent inflammatory reaction resulted in the infiltration of 
the polymorphonuclear leukocyte and red blood cells in the fecal secretion. A study 
has been reported that fecal blood or leukocytes are detectable in the stool in 
approximately 70% of shigellosis cases, whereas both fecal blood and leukocytes are 
detected in approximately 50% of cases (Echeverria et al., 1992). 
 
1.3.2.1.2  Stool culture 
Stool culture remains the gold standard for establishing the definitive diagnosis of 
shigellosis. The laboratory diagnosis of Shigella infection is made by isolating the 
organism from stool specimen and serotyping the isolate. Pure isolates from culture 
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also required for antibiotic susceptibility testing. The successful isolation and 
identification of Shigella can be greatly enhanced when optimal laboratory media 
and techniques are employed. Fresh stool samples collected from patients before 
initiation of antibiotic therapy are preferred for microbiological tests as the chances 
of recovering the organisms are higher (Niyogi, 2005). The patients’ specimens 
should be cultured within 2 to 4 hours after sample collection. The specimens that 
cannot be cultured within this time should be stored at 4°C in buffered glycerol 
saline or Cary-Blair medium for transportation and preservation because Shigella 
spp. is fastidious and survives poorly in stool samples with mixed flora at room 
temperature (Taylor and Schelhart, 1975).  
 
1.3.2.1.2 (a)  Inoculation on selective media 
Isolation of Shigella in the clinical laboratory usually involves an initial streaking for 
isolation on differential or selective media with aerobic incubation to inhibit the 
growth of the anaerobic normal flora. The selective media are commonly used to 
isolate Shigella spp. as previously described. These selective media contain bile salts 
to inhibit the growth of other Gram-positive bacteria and pH indicators to 
differentiate lactose fermenters (coliforms) from non-lactose fermenters (Shigella 
spp.). Inoculation of stool specimens into liquid enrichment broth (Hajna Gram-
negative broth or selenite F broth) may enhance the viability of the organisms before 
subculturing onto the selective media (Theron et al., 2001). Selective media can be 
inoculated with a fecal swab, rectal swab or with a single drop of liquid fecal 
suspension and incubated at 35°C ± 2°C for 18 to 24 hours. Characteristics of the 
colonies appearance on the selective media are as described in the section 1.1.4.2. 
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Identification of the suspected colonies can be achieved by performing biochemical 
and serological tests as described below. 
 
1.3.2.1.2 (b)  Biochemical screening tests 
Biochemical tests are used for further identification of Shigella spp. Suspected well-
isolated colonies from the selective media are inoculated into appropriate screening 
media such as  Kligler iron agar (KIA) or triple sugar iron agar (TSI), motility 
medium, methyl red (MR), Voges-Proskauer (VP), nitrite reduction test, oxidase test 
medium, citrate agar and urea agar. Shigella spp. is usually MR positive and reduces 
nitrates to nitrites and negative for citrate, oxidase, urease, motility and VP test. 
Shigella produces alkaline slant and an acid butt due to the inability to ferment 
lactose aerobically in the slope and the anaerobic fermentation of glucose in the butt, 
and fail to produce H2S gas (Germani and Sansonetti, 2006). 
 
1.3.2.1.2 (c) Serological identification  
Serological testing is performed to confirm and classify the species of the Shigella 
isolates. Each species of Shigella contain a distinct type of O antigen. The 
identification of species is done by performing slide agglutination test using 
commercially available polyvalent O antigen grouping sera. In some cases, specific 
serotype identification is performed by testing with monovalent antisera for 
serotypes and sub-serotypes identification. For serotyping, agglutination test was 
carried out by emulsifying a colony from the surface of TSI or other non-selective 
agar on a drop of normal saline, on a clean glass slide. A drop of polyvalent or 
monovalent antisera is mixed with the bacterial suspension and the slide was tilted 
13 
 
back and forth for approximately 10 seconds. Clear agglutination indicates positive 
result while no agglutination indicates negative results. Cultures that react 
serologically and show strong suggestive results in the biochemical screening tests 
are reported as positive for Shigella (Cheesbrough, 2006). 
 
1.3.2.2  Other diagnostic techniques 
1.3.2.2.1  DNA based technique  
A variety of new molecular technologies are available for rapid diagnosis of 
shigellosis. The conventional methods for determining the presence of certain species 
are time-consuming and labor-intensive. Therefore, the application of molecular 
methods such as PCR may compensate the limitation encountered in conventional 
method for the early diagnosis of shigellosis. Most researchers started to utilize PCR 
for their studies in detection and identification of pathogenic microorganism, 
evaluation of emerging novel infections and surveillance, early detection of 
biological agents and antimicrobial resistance profiling (Lukinmaa et al., 2004). 
Studies have reported that PCR technique is more sensitive and specific than 
conventional culture technique and has the potential to be employed in routine 
diagnosis of dysentery in clinical centres as well as in epidemiological studies (Dutta 
et al., 2001; Aranda et al., 2004; Vu et al., 2004; Ojha et al., 2013). Having 
highlighted advantages and positive aspects in the molecular technique, there are also 
several drawbacks that are encountered during PCR assay. The PCR assay requires 
specialized instrument, trained personnel and relatively expensive reagents. Thus, the 
application of this technology is currently restricted to research laboratories and 
larger clinical laboratories. Besides that, this method also requires careful selection 
of clinical specimen and specimen processing to extract the genetic material. There 
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are also many studies reported the protocol for selective enrichments of the target 
organism need to be carried out in clinical samples containing low number of 
organisms (Feder et al., 2001; Palladino et al., 2003; Sails et al., 2003).  
 
1.3.2.2.2  Protein based technique  
The antibody-based assays such as latex agglutination, immunodiffusion and enzyme 
immunoassays (EIA) format are the rapid methods being used for bacterial 
identification in most laboratories. The EIA is the most common assay used for 
testing large number of samples and is suitable for automation and quantification. 
There are many different EIA methods have been developed for diagnosis of 
shigellosis. A study in Kuwait, has developed a monoclonal antibody-based ELISA 
using a 43 kDa invasion plasmid-coded protein antigen (IpaC) to identify EIEC and 
Shigella strains in fecal samples from children (Pal et al., 1997). ELISA techniques 
have been widely utilized for the detection of serum and urine antibodies of various 
immunoglobulin classes developed against Shigella serogroup specific LPS (Cohen 
et al., 1991; Cohen et al., 1996). A rapid latex agglutination procedure, also known 
as Wellcolex Colour Shigella tests, have been developed for grouping Shigella using 
an antibody attached to multicoloured latex particle (Bouvet and Jeanjean, 1992). 
Another simple test that has been utilized for detection is dot-EIA, in which specific 
antigens or antibodies are immobilized on a nitrocellulose membrane and the 
reaction is observed by enzyme activity. Previous study has demonstrated an 
antigenic membrane protein of 35 kDa in size, which is specific to IgA in sera of 
patients infected with Shigella spp. (Banga Singh, 2001). A simple dot-EIA was 
developed using this protein and diagnostic result of this test could be obtained 
within 3 hours to diagnose shigellosis.  
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1.4  The importance of heat shock proteins (HSPs) 
Heat shock protein (HSP) or also known as stress protein belong to a family of 
essential protein synthesized by a variety of microorganisms including Gram 
negative and Gram positive bacteria, yeast, plant, human cells and even 
archaebacteria (Zhang et al., 1998; Kanagasabai et al., 2011). HSP has been reported 
to be the most highly conserved molecules in living organisms (van Eden, 2012). The 
heat shock response was first discovered in 1962 by Ferrucino Ritossa and his co-
workers. They demonstrated an unusual profile of gene expression in the polytene 
chromosomes of salivary glands induced in Drosophila melanogaster larva (Ritossa, 
1962). The first product of the gene was identified as a heat shock protein (Tissieres 
et al., 1974). 
 
HSPs constitute of a large family of proteins that are often classified based on their 
homology, related function and molecular weight (Chitradevi et al., 2013). HSPs that 
have been classified based on their molecular weight are hsp10, hsp40, hsp60, hsp70, 
hsp90 and hsp100. HSPs are expressed constitutively and their synthesis is up-
regulated following exposure to various forms of stress. The stress situation includes 
environmental (exposure to heat, heavy metal or UV radiation), pathological 
(infection or fever, malignancies, inflammation or autoimmunity) or physiological 
stress (growth factor deprivation, cell differentiation, hormonal stimulation or tissue 
development). HSPs synthesis varies with temperatures but it increases rapidly after 
sudden increase in temperature or in response to other environmental stresses to 
protect the cells from damage (Santoro, 2000; Kiriyama et al., 2001). 
 
16 
 
HSP function as a molecular chaperon to prevent the proteins aggregation in folding 
and unfolding of protein (Kilic and Mandal, 2012). Many molecular chaperones 
described so far are members of hsp60 and hsp70 families. Hsp70 proteins in the 
cytosol are associated with newly formed polypeptides and are directly involved in 
protein transport between different intracellular compartments that lie across 
membranes (Frydman et al., 1994; Hartl, 1996). In E .coli, the hsp70 is a homolog to 
Dnak which stabilizes the newly synthesized proteins and promotes the assembly of 
proteins into multimeric complexes as well during their disassembly process (Hartl, 
1996). Besides the role as a molecular chaperon, hsp70 and hsp90 proteins were also 
reported as immunogens to elicit innate and adaptive immune responses (Basu and 
Srivastava, 2000; Srivastava and Amato, 2001).  
 
Numerous studies reported that the potential of HSP as a therapeutic agents and their 
role in host defence mechanisms are being exploited in the protective vaccine 
development especially in cancer and infectious disease. Most studies reported that 
hsp60 is a potent vaccine candidate against many infectious diseases (Gomez et al., 
1995; Noll and AutenriethIb, 1996; Lee et al., 2006; Carrillo et al., 2008). The 
immunization of mice with recombinant hsp60 from Histoplasma capsulatum 
induced protection against pulmonary histoplasmosis (Gomez et al., 1995). Another 
study proved that the vaccination of mice with recombinant hsp60 protected the 
animal against subsequent infection and development of gastroduodenal disease 
(Ferrero et al., 1995). Several other scientists reported the protective efficacy of 
HSPs against various microorganisms such as Porphyromonas gingivalis (Lee et al., 
2006), Piscirikettsia salmonis (Wilhelm et al., 2005), Yersinia enterocolitica (Noll 
and AutenriethIb, 1996), Paracoccidioides brasiliensis (de Bastos Ascenço Soares et 
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al., 2008), Leishmania infantum (Carrillo et al., 2008) Mycobacterium tuberculosis 
(Lowrie et al., 1997), Candida albicans (Matthews and Burnie, 1992) and Brugia 
malayi (Dakshinamoorthy et al., 2012).  
 
Recently, a study conducted in India to investigate the cross protective efficacy of 
recombinant hsp60 of Salmonella Typhi against various bacterial pathogens such as 
S. dysenteriae type 1, S. flexneri, S. boydii, enteropathogenic E. coli, Klebsiella 
pneumoniae and Pseudomonas aeruginosa (Chitradevi et al., 2013). This study 
reported that, the vaccination of mice with recombinant hsp60 of Salmonella Typhi 
not only conferred protection against Salmonella infections but also elicited cross-
protection against all the tested pathogens. Furthermore, the findings concluded that 
the recombinant hsp60 has the potential to be developed as a single novel vaccine 
candidate against multiple pathogens. 
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1.5  Rationale of study 
Shigellosis is endemic throughout the world and it is a major health concern in most 
impoverished areas, particularly in paediatric population (Phalipon et al., 2008). 
Major obstacles in controlling shigellosis include the ease with which Shigella 
spreads from person to person due to its low infectious dose and its rapidity in 
emergence of antimicrobial resistance strains (Replogle et al., 2000). The clinical 
management of the disease has become difficult due to rapid escalation in antibiotic 
resistance of Shigella spp. even to the newest antibiotics (de Paula et al., 2010). As 
developing antimicrobial resistance to multiple antibiotics causes serious therapeutic 
problems, it is crucial to develop a rapid method to identify the bacteria in order to 
provide appropriate treatment and control the spreading of the disease. The early 
conclusion of definitive diagnosis of shigellosis is crucial to ensure proper clinical 
treatment and management of the infected patient. This would avoid the unnecessary 
prescription of antibiotics and thus would limit the emergence of antibiotic 
resistance.  
 
The current culture method remains as a gold standard to diagnose shigellosis from 
stool samples. Among the drawbacks of this method are time consuming, labour 
intensive, competition in isolation from other commensal organisms and 
inappropriate sample collection. Furthermore, samples are collected after the 
antibiotic therapy, the growth of the pathogen may be impaired as a result of 
sublethal injuries by the antibiotics (Sethabutr et al., 2000). As a result, shigellosis 
remains undiagnosed in a significant number of patients. To overcome these 
problems, an alternative diagnostic method for the early identification of this 
pathogen is needed to control the disease outbreak.  
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The outer membrane of Gram negative bacteria plays many roles in cellular function 
in addition to the classical role of transporting ions through the porin proteins 
(Jyothisri et al., 1999; Silhavy et al., 2010; Galdiero et al., 2012). Protective immune 
response stimulated by OMPs has been documented for several Gram negative 
organisms (Isibasi et al., 1988; Achouak et al., 2001; Galdiero et al., 2003). Bacteria 
exist widely in the diverse environment. During the course of infection, growth of 
bacteria is influenced by various environmental factors including pH, osmotic 
strength, oxygen, iron availability, and temperature, which may change dramatically 
(Guiney, 1997). Thus, the bacteria must adapt to and survive in the new environment. 
Temperature has been described as one of the main factor which regulated the 
expression of microbial protein (Mekalanos, 1992). Studies have been reported that 
certain proteins were overexpressed in response to high temperature such as HSPs 
and serve as defence mechanisms against various environmental stresses (Ellis, 1996; 
Stewart and Young, 2004). Research has also shown that the HSPs are usually 
associated to the virulence of the pathogens (Lathigra et al., 1991; Gophna and Ron, 
2003).  
 
A previous study has reported that Shigella spp. is only capable in invading the 
epithelial cell of human at elevated temperature but not at 37°C (Hale, 1991). As 
such, the HSPs that expressed during higher temperatures may play a role in the 
bacteria to regulate the expression of virulence related proteins. Moreover, the 
immunogenic properties of HSPs have been widely reported in infectious diseases. 
Various studies have proven the capability of HSPs as a protective vaccine candidate 
against bacterial infection (Wilhelm et al., 2005; Lee et al., 2006). In an 
immunoproteomic study conducted in China, the authors discovered the presence of 
20 
 
an immunoreactive hsp70 in S. flexneri 2a (Ying et al., 2005). This hsp70 from S. 
flexneri was shown to have potential in providing protection against shigellosis. To 
date, there is no commercially vaccine available to prevent shigellosis. Thus the 
identification of antigenic HSPs can be potential candidate for vaccine and 
diagnostics development.  
 
The main aim of this study is to identify the presence of HSPs in the outer membrane 
protein of S. flexneri and S. sonnei as biomarker(s). These proteins can be used to 
develop rapid and reliable protein based diagnostic tests for the identification of 
Shigella spp. which would significantly improve effective management of the disease 
especially among young children. 
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1.6  Objectives of the study 
1. To study the outer membrane proteins (OMPs) profiles of S. flexneri and S. 
sonnei expressed at 37°C, 38.5°C and 40°C by sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS-PAGE). 
  
2. To study the antigenic profiles of the OMPs expressed at 37°C by Western 
blot analysis using patient’s sera positive for S. flexneri and S. sonnei toward 
the identification of potential biomarker(s) for serodiagnosis of shigellosis.  
 
3. To identify the OMPs of S. flexneri and S. sonnei that showed prominent 
increase in expression at 40°C by mass spectrometry method. 
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Figure 1.1:  Flow chart of this study 
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CHAPTER TWO 
MATERIALS AND METHODS 
 
2.1  Materials 
 
2.1.1  Bacteria 
Clinical strains, S. flexneri SH057 and S. sonnei SH080 strains used in this study 
were obtained from the Department of Medical Microbiology and Parasitology, 
School of Medical Sciences, Health Campus, USM. S. flexneri ATCC 12022 and S. 
sonnei ATCC 25931 were used as the reference strain in this study. 
 
2.1.2  Growth and maintenance of bacterial strains 
S. flexneri ATCC 12022, S. sonnei ATCC 25931 and the clinical isolates were 
maintained in TSB-glycerol (10%) and kept at -20°C. For experimental purposes, the 
organism was grown in nutrient broth at 37°C for 18 hours and was subcultured on 
blood agar to check for its purity. Shigella spp. was confirmed by biochemical tests 
such as TSI (Triple sugar iron agar), SIM (sulfide-indole motility medium), urease, 
and methyl red (MR) and citrate utilization test. For serological testing, antisera 
Shigella flexneri 2a and Shigella sonnei (Denka Seiken, Japan) were used. In order to 
perform biochemical test, a single translucent colony was picked up from 
MacConkey agar. For serotyping purpose, colonies were picked from TSI agar and it 
was resuspended in a drop of normal saline on a glass slide. A drop of antisera was 
mixed with the bacterial suspension and the slide was tilted back and forth for 10 
seconds. Clear agglutination shows positive results while no agglutination indicates 
negative results.  
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2.1.3  Sera samples  
Prior to the collection of samples, permission was obtained from patients using 
consent letter as shown in the (Appendix A). Samples were collected from consented 
patients admitted in the ward at Hospital Universiti Sains Malaysia, Kelantan, 
immediately after the laboratory culture results were confirmed. The collected sera 
samples were stored in aliquots at -20°C until needed. Sera samples used in this 
study are as listed in Table 2.1. In the Western blot analysis, panel of sera were 
obtained from patients infected with S. flexneri, S. sonnei and other infections 
(Salmonella Typhi, Salmonella spp, enteropathogenic Escherichia coli (EPEC), 
Aeromonas hydrophila and Campylobacter jejuni.  
 
2.1.4  Chemicals and media 
All the chemicals, reagents and media used in this study as listed in the Table 2.2 
were electrophoresis, molecular or analytical grade. 
 
2.1.4.1  Media 
The appropriate media were autoclaved at 121°C, 15 psi for 15 minutes and tested 
for sterility by incubating at 37°C overnight to check for contamination. The media 
were stored at 4°C prior to use. 
 
 
 
 
 
 
